blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2943495

EP2943495 - PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.11.2017
Database last updated on 14.06.2024
FormerThe patent has been granted
Status updated on  25.11.2016
FormerGrant of patent is intended
Status updated on  22.11.2016
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Savira pharmaceuticals GmbH
Veterinärplatz 1
Building 1A
1210 Vienna / AT
For all designated states
European Molecular Biology Laboratory
Meyerhofstrasse 1
69117 Heidelberg / DE
[2017/30]
Former [2015/47]For all designated states
Savira Pharmaceuticals GmbH
Veterinärplatz 1 Building 1A
1210 Vienna / AT
For all designated states
F. Hoffmann-La Roche AG
Grenzacherstraße 124
4070 Basel / CH
For all designated states
European Molecular Biology Laboratory
Meyerhofstrasse 1
69117 Heidelberg / DE
Inventor(s)01 / Wolkerstorfer, Andrea
Urbangasse 8/25-26
A-1170 Vienna / AT
02 / Szolar, Oliver
Gugitzgasse 5/1
A-1190 Vienna / AT
03 / Handler, Norbert
Neuwaldegger Straße 35/2/3
A-1170 Vienna / AT
04 / Buschmann, Helmut
Sperberweg 15
52076 Aachen / DE
05 / Cusack, Stephen
653 Route de St. Nizier
F-38170 Seyssinet-Pariset / FR
06 / Smith, Mark
1080 Sutter Street
Apartment 401
San Francisco California 94109 / US
07 / So, Sung-Sau
11 Westover Road
Verona New Jersey 07044 / US
08 / Hawley, Ronald Charles
1539 Trestle Glen Road
Oakland, CA, 94610 / US
09 / Sidduri, Achyutharao
Aunova Medchem LLC
211 Warren Street
Newark, New Jersey 07103 / US
10 / Zhang, Zhuming
59 Wesley Road
Hillsborough, New Jersey 08844 / US
 [2016/52]
Former [2015/47]01 / Wolkerstorfer, Andrea
Urbangasse 8/25-26
A-1170 Vienna / AT
02 / Szolar, Oliver
Gugitzgasse 5/1
A-1190 Vienna / AT
03 / Handler, Norbert
Neuwaldegger Straße 35/2/3
A-1170 Vienna / AT
04 / Buschmann, Helmut
Sperberweg 15
52076 Aachen / DE
05 / Cusack, Stephen
653 Route de St. Nizier
F-38170 Seyssinet-Pariset / FR
06 / Smith, Mark
1080 Sutter Street
Apartment 401
San Francisco California 94109 / US
07 / So, Sung-Sau
11 Westover Road
Verona New Jersey 07044 / US
08 / Hawley, Ronald Charles
255 King Street Apt. 810
San Francisco, California 94107 / US
09 / Sidduri, Achyutharao
Aunova Medchem LLC
211 Warren Street
Newark, New Jersey 07103 / US
10 / Zhang, Zhuming
59 Wesley Road
Hillsborough, New Jersey 08844 / US
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2015/47]
Application number, filing date14703275.907.01.2014
[2015/47]
WO2014EP50165
Priority number, dateUS201361750017P08.01.2013         Original published format: US 201361750017 P
[2015/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014108406
Date:17.07.2014
Language:EN
[2014/29]
Type: A1 Application with search report 
No.:EP2943495
Date:18.11.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 17.07.2014 takes the place of the publication of the European patent application.
[2015/47]
Type: B1 Patent specification 
No.:EP2943495
Date:28.12.2016
Language:EN
[2016/52]
Search report(s)International search report - published on:EP17.07.2014
ClassificationIPC:C07D487/04, A61K31/519, A61P31/12
[2015/47]
CPC:
C07D487/04 (EP,CN,US); C07D403/04 (EP,CN,US); A61K31/519 (EP,US);
A61K45/06 (US); A61P31/12 (EP); A61P31/14 (EP);
A61P31/16 (EP); A61P31/22 (EP); C07D471/04 (EP,CN,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/47]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:PYRIMIDONDERIVATE UND DEREN VERWENDUNG BEI DER BEHANDLUNG, LINDERUNG ODER PRÄVENTION EINER VIRUSERKRANKUNG[2016/24]
English:PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE[2015/47]
French:DÉRIVÉS DE PYRIMIDONE ET LEUR UTILISATION DANS LE TRAITEMENT, L'AMÉLIORATION OU LA PRÉVENTION D'UNE MALADIE VIRALE[2016/24]
Former [2015/47]PYRIDONDERIVATE UND DEREN VERWENDUNG BEI DER BEHANDLUNG, LINDERUNG ODER PRÄVENTION EINER VIRUSERKRANKUNG
Former [2015/47]DÉRIVÉS PYRIMIDONE ET LEUR UTILISATION DANS LE TRAITEMENT, L'AMÉLIORATION OU LA PRÉVENTION D'UNE MALADIE VIRALE
Entry into regional phase08.08.2015National basic fee paid 
08.08.2015Designation fee(s) paid 
08.08.2015Examination fee paid 
Examination procedure07.08.2014Request for preliminary examination filed
International Preliminary Examining Authority: EP
07.08.2015Amendment by applicant (claims and/or description)
08.08.2015Examination requested  [2015/47]
07.07.2016Communication of intention to grant the patent
17.11.2016Fee for grant paid
17.11.2016Fee for publishing/printing paid
17.11.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.07.2016
Opposition(s)29.09.2017No opposition filed within time limit [2017/49]
Fees paidRenewal fee
25.01.2016Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.01.2014
AL28.12.2016
AT28.12.2016
BE28.12.2016
CY28.12.2016
CZ28.12.2016
DK28.12.2016
EE28.12.2016
ES28.12.2016
FI28.12.2016
HR28.12.2016
IT28.12.2016
LT28.12.2016
LV28.12.2016
MC28.12.2016
MK28.12.2016
NL28.12.2016
PL28.12.2016
RO28.12.2016
RS28.12.2016
SE28.12.2016
SI28.12.2016
SK28.12.2016
SM28.12.2016
TR28.12.2016
IE07.01.2017
LU07.01.2017
MT07.01.2017
BG28.03.2017
NO28.03.2017
GR29.03.2017
IS28.04.2017
PT28.04.2017
[2020/34]
Former [2020/15]HU07.01.2014
AT28.12.2016
BE28.12.2016
CY28.12.2016
CZ28.12.2016
DK28.12.2016
EE28.12.2016
ES28.12.2016
FI28.12.2016
HR28.12.2016
IT28.12.2016
LT28.12.2016
LV28.12.2016
MC28.12.2016
MK28.12.2016
NL28.12.2016
PL28.12.2016
RO28.12.2016
RS28.12.2016
SE28.12.2016
SI28.12.2016
SK28.12.2016
SM28.12.2016
TR28.12.2016
IE07.01.2017
LU07.01.2017
MT07.01.2017
BG28.03.2017
NO28.03.2017
GR29.03.2017
IS28.04.2017
PT28.04.2017
Former [2019/52]HU07.01.2014
AT28.12.2016
BE28.12.2016
CY28.12.2016
CZ28.12.2016
DK28.12.2016
EE28.12.2016
ES28.12.2016
FI28.12.2016
HR28.12.2016
IT28.12.2016
LT28.12.2016
LV28.12.2016
MC28.12.2016
MK28.12.2016
NL28.12.2016
PL28.12.2016
RO28.12.2016
RS28.12.2016
SE28.12.2016
SI28.12.2016
SK28.12.2016
SM28.12.2016
IE07.01.2017
LU07.01.2017
MT07.01.2017
BG28.03.2017
NO28.03.2017
GR29.03.2017
IS28.04.2017
PT28.04.2017
Former [2019/47]HU07.01.2014
AT28.12.2016
BE28.12.2016
CY28.12.2016
CZ28.12.2016
DK28.12.2016
EE28.12.2016
ES28.12.2016
FI28.12.2016
HR28.12.2016
IT28.12.2016
LT28.12.2016
LV28.12.2016
MC28.12.2016
NL28.12.2016
PL28.12.2016
RO28.12.2016
RS28.12.2016
SE28.12.2016
SI28.12.2016
SK28.12.2016
SM28.12.2016
IE07.01.2017
LU07.01.2017
MT07.01.2017
BG28.03.2017
NO28.03.2017
GR29.03.2017
IS28.04.2017
PT28.04.2017
Former [2019/31]HU07.01.2014
AT28.12.2016
BE28.12.2016
CZ28.12.2016
DK28.12.2016
EE28.12.2016
ES28.12.2016
FI28.12.2016
HR28.12.2016
IT28.12.2016
LT28.12.2016
LV28.12.2016
MC28.12.2016
NL28.12.2016
PL28.12.2016
RO28.12.2016
RS28.12.2016
SE28.12.2016
SI28.12.2016
SK28.12.2016
SM28.12.2016
IE07.01.2017
LU07.01.2017
MT07.01.2017
BG28.03.2017
NO28.03.2017
GR29.03.2017
IS28.04.2017
PT28.04.2017
Former [2018/43]AT28.12.2016
BE28.12.2016
CZ28.12.2016
DK28.12.2016
EE28.12.2016
ES28.12.2016
FI28.12.2016
HR28.12.2016
IT28.12.2016
LT28.12.2016
LV28.12.2016
MC28.12.2016
NL28.12.2016
PL28.12.2016
RO28.12.2016
RS28.12.2016
SE28.12.2016
SI28.12.2016
SK28.12.2016
SM28.12.2016
IE07.01.2017
LU07.01.2017
MT07.01.2017
BG28.03.2017
NO28.03.2017
GR29.03.2017
IS28.04.2017
PT28.04.2017
Former [2018/13]AT28.12.2016
BE28.12.2016
CZ28.12.2016
DK28.12.2016
EE28.12.2016
ES28.12.2016
FI28.12.2016
HR28.12.2016
IT28.12.2016
LT28.12.2016
LV28.12.2016
MC28.12.2016
NL28.12.2016
PL28.12.2016
RO28.12.2016
RS28.12.2016
SE28.12.2016
SI28.12.2016
SK28.12.2016
SM28.12.2016
IE07.01.2017
LU07.01.2017
BG28.03.2017
NO28.03.2017
GR29.03.2017
IS28.04.2017
PT28.04.2017
Former [2018/01]AT28.12.2016
BE28.12.2016
CZ28.12.2016
DK28.12.2016
EE28.12.2016
ES28.12.2016
FI28.12.2016
HR28.12.2016
IT28.12.2016
LT28.12.2016
LV28.12.2016
MC28.12.2016
NL28.12.2016
PL28.12.2016
RO28.12.2016
RS28.12.2016
SE28.12.2016
SK28.12.2016
SM28.12.2016
LU07.01.2017
BG28.03.2017
NO28.03.2017
GR29.03.2017
IS28.04.2017
PT28.04.2017
Former [2017/42]AT28.12.2016
BE28.12.2016
CZ28.12.2016
EE28.12.2016
ES28.12.2016
FI28.12.2016
HR28.12.2016
IT28.12.2016
LT28.12.2016
LV28.12.2016
MC28.12.2016
NL28.12.2016
PL28.12.2016
RO28.12.2016
RS28.12.2016
SE28.12.2016
SK28.12.2016
SM28.12.2016
BG28.03.2017
NO28.03.2017
GR29.03.2017
IS28.04.2017
PT28.04.2017
Former [2017/41]AT28.12.2016
BE28.12.2016
CZ28.12.2016
EE28.12.2016
ES28.12.2016
FI28.12.2016
HR28.12.2016
IT28.12.2016
LT28.12.2016
LV28.12.2016
NL28.12.2016
PL28.12.2016
RO28.12.2016
RS28.12.2016
SE28.12.2016
SK28.12.2016
SM28.12.2016
BG28.03.2017
NO28.03.2017
GR29.03.2017
IS28.04.2017
PT28.04.2017
Former [2017/37]AT28.12.2016
BE28.12.2016
CZ28.12.2016
EE28.12.2016
ES28.12.2016
FI28.12.2016
HR28.12.2016
IT28.12.2016
LT28.12.2016
LV28.12.2016
NL28.12.2016
PL28.12.2016
RO28.12.2016
RS28.12.2016
SE28.12.2016
SK28.12.2016
SM28.12.2016
NO28.03.2017
GR29.03.2017
IS28.04.2017
Former [2017/36]BE28.12.2016
CZ28.12.2016
EE28.12.2016
ES28.12.2016
FI28.12.2016
HR28.12.2016
LT28.12.2016
LV28.12.2016
NL28.12.2016
PL28.12.2016
RO28.12.2016
RS28.12.2016
SE28.12.2016
SK28.12.2016
NO28.03.2017
GR29.03.2017
IS28.04.2017
Former [2017/34]CZ28.12.2016
FI28.12.2016
HR28.12.2016
LT28.12.2016
LV28.12.2016
NL28.12.2016
RS28.12.2016
SE28.12.2016
BE31.01.2017
NO28.03.2017
GR29.03.2017
Former [2017/31]FI28.12.2016
HR28.12.2016
LT28.12.2016
LV28.12.2016
NL28.12.2016
RS28.12.2016
SE28.12.2016
BE31.01.2017
NO28.03.2017
GR29.03.2017
Former [2017/28]FI28.12.2016
HR28.12.2016
LT28.12.2016
LV28.12.2016
RS28.12.2016
SE28.12.2016
BE31.01.2017
NO28.03.2017
GR29.03.2017
Former [2017/12]LV28.12.2016
Cited inInternational search[XD]WO2005087766  (ANGELETTI P IST RICHERCHE BIO [IT], et al) [XD] 1,2,4-6,8 * claims 1, 12; table 1 *;
 [A]WO2007014352  (GILEAD SCIENCES INC [US], et al) [A] 1-15* page 122; compound 11 *;
 [A]CA2812363  (SHIONOGI & CO [JP]) [A] 1-15 * paragraphs [0102] , [ 0198]; examples 36-42, 46, 47, 50; claims 1, 22, 23 *
by applicantUS5475109
 WO2005087766
 WO2006030807
 US2007072831
 WO2010110231
 WO2010110409
 WO2011000566
 WO2012039414
 EP2444400
    - NEUMANN ET AL., NATURE, (20081218), vol. 459, no. 7249, pages 931 - 939
    - DHARAN ET AL., THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, (20090311), vol. 301, no. 10, pages 1034 - 1041
    - MOSCONA ET AL., THE NEW ENGLAND JOURNAL OF MEDICINE, (20090305), vol. 360, no. 10, pages 953 - 956
    - VON ITZSTEIN, M. ET AL., NATURE, (1993), vol. 363, pages 418 - 423
    - MAGDEN, J. ET AL., APPL. MICROBIOL. BIOTECHNOL., (2005), vol. 66, pages 612 - 621
    - ERIKSSON, B. ET AL., ANTIMICROB. AGENTS CHEMOTHER, (1977), vol. 11, pages 946 - 951
    - FURUTA ET AL., ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, (2005), pages 981 - 986
    - GUILLIGAY ET AL., NATURE STRUCTURAL & MOLECULAR BIOLOGY, (200805), vol. 15, no. 5, pages 500 - 506
    - DIAS ET AL., NATURE, (2009), vol. 458, pages 914 - 918
    - PLOTCH, S. J. ET AL., CELL, (1981), vol. 23, pages 847 - 858
    - KUKKONEN, S. K. ET AL., ARCH. VIROL., (2005), vol. 150, pages 533 - 556
    - LEAHY, M. B. ET AL., J. VIROL., (2005), vol. 71, pages 8347 - 8351
    - NOAH, D. L. ET AL., ADV. VIRUS RES., (2005), vol. 65, pages 121 - 145
    - GHANEM, A. ET AL., J. VIROL., (2007), vol. 81, pages 7801 - 7804
    - TOMASSINI, J. ET AL., ANTIMICROB. AGENTS CHEMOTHER., (1994), vol. 38, pages 2827 - 2837
    - TOMASSINI, J. ET AL., ANTIMICROB. AGENTS CHEMOTHER., (1996), vol. 40, pages 1189 - 1193
    - TISDALE, M. ET AL., ANTIMICROB. AGENTS CHEMOTHER., (1995), vol. 39, pages 2454 - 2458
    - S. M. BERGE ET AL., "Pharmaceutical Salts", J. PHARM. SCI., (1977), vol. 66, doi:doi:10.1002/jps.2600660104, pages 1 - 19, XP002675560

DOI:   http://dx.doi.org/10.1002/jps.2600660104
    - N. DAS ET AL., EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, (2010), vol. 41, pages 571 - 588
    - NING SHAN ET AL., DRUG DISCOVERY TODAY, (2008), vol. 13, no. 9-10, pages 440 - 446
    - D. J. GOOD ET AL., CRYST. GROWTH DES., (2009), vol. 9, no. 5, pages 2252 - 2264
    - CHANG ET AL., ANTIVIRAL RESEARCH, (2011), vol. 89, pages 26 - 34
    - DIAS ET AL., NATURE, (20090416), vol. 458, no. 7240, pages 914 - 918
    - JOEL R. CALVIN ET AL., ORG. LETT., (2012), vol. 14, no. 4, pages 1038 - 1041
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.